Prospective Randomised Trial of The Use of Daclizumab in Renal Transplantation from Non-Heart Beating Donors

Related articles

26 Apr 2019 : Original article

Living Anonymous Renal Donors Do Not Regret: Intermediate and Long-Term Follow-Up with a Focus on Motives and Psychosocial Outcomes

Jonas Wadström, Bengt von Zur-Mühlen, [...] Annette Lennerling, Kerstin Westman, Lars Wennberg, Ingela Fehrman Ekholm - Show fewer authors

DOI: 10.12659/AOT.913827

11 Feb 2016 : Original article

Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program (ESP): A Single-Center Experience from 2008 to 2013

Johannes Jacobi, Sophie Beckmann, [...] Katharina Heller, Karl F. Hilgers, Hendrik Apel, Bernd Spriewald, Kai-Uwe Eckardt, Kerstin U. Amann - Show fewer authors

DOI: 10.12659/AOT.895731

17 Nov 2017 : Clinical Research

Proton Nuclear Magnetic Resonance (¹H-NMR)-Based Metabolomic Evaluation of Human Renal Allografts from Donations After Circulatory Death

Zijie Wang, Haiwei Yang, [...] Chunchun Zhao, Jifu Wei, Junsong Wang, Zhijian Han, Jun Tao, Zhen Xu, Xiaobin Ju, Ruoyun Tan, Min Gu - Show fewer authors

DOI: 10.12659/MSM.905168

12 Sep 2017 : Review article

Eculizumab in Renal Transplantation: A 2017 Update

Ryszard Grenda, Magdalena Durlik

DOI: 10.12659/AOT.905917

24 Apr 2018 : Original article

Oxygen Consumption of the Aerobically-Perfused Cardioplegic Donor Heart at Different Temperatures

Guangqi Qin, Yang Su, [...] Trygve Sjöberg, Stig Steen - Show fewer authors

DOI: 10.12659/AOT.907753